(Q39961330)

15 September 2017

An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines (English)

1 reference

15 September 2017

1 reference

Eleftherios P. Diamandis

series ordinal

2

1 reference

15 September 2017

Miltiadis Paliouras

1

1 reference

PubMed ID

18627304

15 September 2017

language of work or name

1 reference

1 June 2008

1 reference

15 September 2017

1 reference

15 September 2017

389

1 reference

15 September 2017

6

1 reference

15 September 2017

773-780

1 reference

Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration.

15 September 2017

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Biology of prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Signaling mechanisms that mediate invasion in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Induction and regulation of epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Androgen receptor signaling in androgen-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

EGFR signaling pathway negatively regulates PSA expression and secretion via the PI3K-Akt pathway in LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Function of nuclear sex hormone receptors in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Prostate specific antigen gene regulation by androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

The epithelial-mesenchymal transition: new insights in signaling, development, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

The emerging role of the PI3-K-Akt pathway in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Mechanisms underlying the development of androgen-independent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Ras oncogenes and their downstream targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Molecular biology of prostate-cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Androgen receptor involvement in the progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Androgen-regulated gene expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Molecular characterization of human prostate carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

HER2 overexpression and cancer targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.072

21 January 2018

Identifiers

DOI

10.1515/BC.2008.072

1 reference

release_k3td7pldr5cb7isaflun4gubgi

15 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k3td7pldr5cb7isaflun4gubgi

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

18627304

1 reference

PubMed ID

18627304